Back
Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.
Current location in your website.
Skip to main contents.
Printer Friendly Page starts here.
Start main contents.

Principle Technology Licensing Agreements

 

1. Licensed-out technologies (overseas)

  Company Country Agreement
2010 Ferrer Internacional, S.A Spain Patent for T-3811
2006 Dong-A Pharmaceutical Co., Ltd Korea Patent for T-3811
2004 Schering-plough Corporation US Patent for T-3811
2004 Dong-A Pharmaceutical Co., Ltd Korea Patent for TN-3262a
2002 Dong-A Pharmaceutical Co., Ltd Korea Patent for T-614
2001 Ferrer Internacional, S.A Spain Patent for T-3912
1990 Cyanamid International Corporation Limited Bermuda Patent for Tosufloxacin tosilate
1983 Bristol-Myers Co. US Manufacturing patent for intermediary used in production of cephalosporin
1981 F. Hoffman-La Roche Ltd Swizerland Manufacturing patent for intermediary used in production of cephalosporin
1979 Lederle Piperacillin Inc. US Patent for Piperacillin
1978 Pfizer Inc. US Patent for Cefoperazone

2. Licensed-in technologies (overseas)

  Company Country Agreement
1992 Pfizer Inc. US Patent for Ampiroxicam

3. Cross-Licensing Agreements

  Company Country Agreement
1988 Abbott International Inc. US Cross license for Tosufloxacin tosilate

4. License Agreements (Japan)

  Company In / Out Agreement
2006 Astellas Pharma Out Joint development and Marketing right for T-3811
2003 Otsuka Pharmaceutical Out Marketing right for TN-3262a
2003 Taisho Pharmaceutical Out Marketing right for T-614
2002 Taisho Pharmaceutical Out Marketing right for T-3811
2002 Novartis Pharma In Marketing right for HALOSPOR
2001 Maruho Out Patent for T-3912
1999 Yoshitomi Pharmaceutical Industries In Marketing right for LUPRAC
1998 Eisai Out Patent, Co-development, Co-marketing and bulk supply for T-614
1992 Green Cross Out Co-developmet and co-marketing right for Pazufloxacin mesilate
1991 Taiho Pharmaceutical In Co-development and co-marketing right for YP-14
1988 Abbott Japan Out Patent for Tosufloxacin tosilate

Back to Top
Footer starts here.
Pages ends here.
Move to top of the page.
Back
About Printer Friendly Page
  • To go back to the normal view page, click on “Back” either on the top or the bottom of this page.
  • The printer friendly page is optimized for printing, therefore, some parts may be displayed differently from the normal view page. In the case CSS (Cascading Style Sheets) is not supported or configured as active on your browser, the printer friendly page cannot be optimized.
  • To print all the contents on the normal view page, use the print function of your browser on the normal view.
  • The “Back” and “Print” buttons, and “About Printer Friendly Page” displayed on this page are not printed out.